Daniel Sterman
Overview
Explore the profile of Daniel Sterman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
696
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blyth K, Adusumilli P, Astoul P, Darlison L, Lee Y, Mansfield A, et al.
Lancet Respir Med
. 2024 May;
12(6):476-483.
PMID: 38740045
Most patients with pleural mesothelioma (PM) present with symptomatic pleural effusion. In some patients, PM is only detectable on the pleural surfaces, providing a strong rationale for intrapleural anticancer therapy....
2.
Velez A, DeMaio A, Sterman D
Front Immunol
. 2023 Sep;
14:1203539.
PMID: 37671163
Despite remarkable advances in tumor response and patient survival in the past decade, systemic immunotherapies for lung cancer result in an objective response in only around half of patients treated....
3.
Cantini L, Laniado I, Murthy V, Sterman D, Aerts J
Lung Cancer
. 2022 Feb;
165:91-101.
PMID: 35114509
Malignant pleural mesothelioma (MPM) is an aggressive neoplasm with low survival rates. Platinum-based chemotherapy has represented the cornerstone of treatment for over a decade, prompting the investigation of new therapeutic...
4.
Sulaiman I, Chung M, Angel L, Koralov S, Wu B, Yeung S, et al.
Res Sq
. 2021 Apr;
PMID: 33791687
Mortality among patients with COVID-19 and respiratory failure is high and there are no known lower airway biomarkers that predict clinical outcome. We investigated whether bacterial respiratory infections and viral...
5.
Sulica R, Cefali F, Motschwiller C, Fenton R, Barroso A, Sterman D
Diagnostics (Basel)
. 2021 Jan;
11(1).
PMID: 33467533
Information on outcomes of COVID-19 in pulmonary arterial hypertension (PAH) patients is limited to a few case series and surveys. Here, we describe our experience at a large Pulmonary Hypertension...
6.
DeMaio A, Sterman D
Eur Respir Rev
. 2020 Jun;
29(156).
PMID: 32554757
The past decade has brought remarkable improvements in the treatment of non-small cell lung cancer (NSCLC) with novel therapies, such as immune checkpoint inhibitors, although response rates remain suboptimal. Direct...
7.
Kindler H, Rusch V, Bueno R, Ismaila N, Pass H, Sterman D, et al.
J Clin Oncol
. 2018 Jun;
36(26):2746-2747.
PMID: 29902108
No abstract available.
8.
Kindler H, Ismaila N, Armato 3rd S, Bueno R, Hesdorffer M, Jahan T, et al.
J Clin Oncol
. 2018 Jan;
36(13):1343-1373.
PMID: 29346042
Purpose To provide evidence-based recommendations to practicing physicians and others on the management of malignant pleural mesothelioma. Methods ASCO convened an Expert Panel of medical oncology, thoracic surgery, radiation oncology,...
9.
DiBardino D, Haas A, Lanfranco A, Litzky L, Sterman D, Bessich J
Ann Am Thorac Soc
. 2017 Jul;
14(7):1230.
PMID: 28665703
No abstract available.
10.
DiBardino D, Lanfranco A, Haas A, Litzky L, Sterman D, Bessich J
Ann Am Thorac Soc
. 2017 Jul;
14(7):1231-1232.
PMID: 28665699
No abstract available.